Rituximab or irradiation promotes IL-17 secretion and thereby induces resistance to rituximab or irradiation

Cell Mol Immunol. 2017 Dec;14(12):1020-1022. doi: 10.1038/cmi.2017.124. Epub 2017 Nov 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Interleukin-17 / metabolism*
  • Interleukin-6 / metabolism
  • Lymphoma / drug therapy*
  • Lymphoma / radiotherapy*
  • Mice
  • Models, Biological
  • Rituximab / pharmacology
  • Rituximab / therapeutic use*

Substances

  • Interleukin-17
  • Interleukin-6
  • Rituximab